Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

0%

0 of 10 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (13)
Early P 1 (1)
P 2 (1)
P 3 (2)

Trial Status

Completed10
Recruiting8
Not Yet Recruiting2
Withdrawn1
Unknown1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT06730984Not ApplicableCompleted

Endoscopy-Assisted Tracheal Intubation Versus Conventional Tracheal Intubation for Endoscopic Submucosal Dissection (ESD)

NCT06805123Not ApplicableRecruitingPrimary

Early Feeding Versus Delayed Feeding After Colorectal Endoscopic Submucosal Dissection

NCT07495137Not ApplicableNot Yet RecruitingPrimary

The Improvement Effect of Real-time Artificial Intelligence Assisted Identification of Bleeding Points on Hemostasis Efficiency in Endoscopic Submucosal Dissection

NCT06476678Recruiting

Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions

NCT06766162Not ApplicableCompleted

Virtual Reality to Improve Patient Experience During Endoscopic Mucosal and Submucosal Resection

NCT06549894Not ApplicableActive Not RecruitingPrimary

Evaluation of Biomechanical Forced During the Practice of Endoscopic Submucosal Dissection

NCT07305857Not ApplicableNot Yet RecruitingPrimary

Comparison of the Effects of Target-Controlled Infusion Method and Manual Propofol Administration on Respiratory Function, Recovery, and Electroencephalogram in Endoscopic Submucosal Dissection Cases

NCT04780256Recruiting

Endoscopic Resection of Gastrointestinal Neoplasms

NCT02989818RecruitingPrimary

Multi-center Evaluation of the Clinical Utility of ESD in the Western Population

NCT03039309RecruitingPrimary

Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom

NCT06840561Phase 2Completed

Local Triamcinolone Injection Combined With Fibrin Glue Spray in Preventing Esophageal Stricture After Big-range Endoscopic Submucosal Dissection for Esophageal Early Cancer

NCT06748352Not ApplicableRecruiting

Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer

NCT06611176Not ApplicableRecruitingPrimary

Local LevoBupivacaine for Pain Relief After Endoscopic Submucosal Dissection for Esophageal Lesions

NCT05407870Not ApplicableCompleted

Efficacy and Safety of Etomidate Sedation in Gastric Endoscopic Submucosal Dissection

NCT05736705Not ApplicableWithdrawn

Monopolar and Bipolar in Esophageal ESD

NCT05265221CompletedPrimary

Learning Curve for Gastric Endoscopic Submucosal Dissection

NCT05323929Not ApplicableRecruiting

The Relationship Between Scar Formation and ESD Depth in Therapy for Gastric Carcinoma

NCT04482491CompletedPrimary

Histological Prediction and Choice of the Resection Strategy in Front of a Colorectal Lesion > 2 cm: Prospective Comparison of Endoscopic Characterization, Non-targeted and Targeted Biopsies

NCT02931149Phase 3Completed

Evaluation of the Efficacy of Platelet-rich Plasma (PRP) on Advanced Endoscopic Resection Techniques

NCT03220334Phase 3Completed

Healing Effects of Autologous Platelet Rich Plasma on Gastric Ulcer Caused by Endoscopic Submucosal Dissection

Scroll to load more

Research Network

Activity Timeline